BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 113341
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.113341
Figure 1
Figure 1 Baseline computed tomography of the abdomen. A: Arterial phase computed tomography (CT) showed a large, well-defined hypervascular hepatic mass; B: Delayed phase CT demonstrated washout of the mass with an enhancing peripheral rim (tumor capsule).
Figure 2
Figure 2 Baseline magnetic resonance imaging of the abdomen. A: Arterial phase T1-weighted magnetic resonance imaging showed a large, well-defined, arterially enhancing hepatic mass; B: Delayed phase T1-weighted magnetic resonance imaging demonstrated washout of the lesion.
Figure 3
Figure 3 Digital subtraction angiography images during the first drug-eluting bead transarterial chemoembolization session in Case 1. A: Right hepatic artery non-selective angiogram; B: Selective hepatic angiogram showed a hypervascular mass; C: Superselective angiogram demonstrated complete stasis of the vascular supply of the tumor after embolization.
Figure 4
Figure 4 Digital subtraction angiography images during the first drug-eluting bead transarterial chemoembolization session in Case 2. A: Celiac angiogram showed a large hypervascular hepatic mass; B: Right hepatic lobar angiogram showed tumor supply by multiple right hepatic artery branches; C: Post-embolization angiogram demonstrated complete stasis of tumor supply.
Figure 5
Figure 5 Six-week follow-up computed tomography of the abdomen after the first drug-eluting bead transarterial chemoembolization in Case 1. A: Arterial phase computed tomography (CT) showed a residual hypervascular nodule at the periphery of the non-enhancing treated mass, indicating partial response; B: Delayed phase CT confirmed washout of the residual soft tissue nodule.
Figure 6
Figure 6 Four-week follow-up computed tomography of the abdomen after the second drug-eluting bead transarterial chemoembolization in Case 1. A: Arterial phase computed tomography (CT) showed a non-enhancing mass, consistent with complete response; B: Portal venous phase CT demonstrated normal hepatic parenchymal enhancement with a necrotic treated mass.
Figure 7
Figure 7 One-year follow-up computed tomography of the abdomen after the second drug-eluting bead transarterial chemoembolization in Case 1. A: Pre-contrast computed tomography (CT) demonstrated faint linear peripheral calcification of the treated hepatic mass; B: Arterial phase CT showed a non-enhancing mass, consistent with complete response.
Figure 8
Figure 8 Six-year follow-up computed tomography of the abdomen after the second drug-eluting bead transarterial chemoembolization in Case 1. A: Pre-contrast computed tomography (CT) demonstrated progressive peripheral concentric calcification encircling the treated hepatic mass; B: Arterial phase CT showed a non-enhancing mass, consistent with sustained complete response.
Figure 9
Figure 9 Eight-week follow-up magnetic resonance imaging of the abdomen after the first drug-eluting bead transarterial chemoembolization in Case 2. A: Arterial phase magnetic resonance imaging showed a residual hypervascular nodule at the periphery of the treated mass, indicating partial response; B: Delayed phase magnetic resonance imaging demonstrated washout of the residual soft tissue nodule.
Figure 10
Figure 10  Six-week follow-up computed tomography of the abdomen after the second drug-eluting bead transarterial chemoembolization in Case 2. A: Arterial phase computed tomography (CT) showed a non-enhancing treated mass, consistent with complete response; B: Portal venous phase CT demonstrated normal hepatic parenchymal enhancement with a necrotic treated mass.
Figure 11
Figure 11  One-year follow-up computed tomography of the abdomen after the second drug-eluting bead transarterial chemoembolization in Case 2. A: Pre-contrast computed tomography (CT) demonstrated faint linear peripheral calcification of the treated hepatic mass; B: Arterial phase CT showed a non-enhancing mass, consistent with complete response.
Figure 12
Figure 12  Six-year follow-up computed tomography of the abdomen after the second drug-eluting bead transarterial chemoembolization in Case 2. A: Pre-contrast computed tomography (CT) demonstrated dense, progressive peripheral concentric calcification surrounding the treated hepatic mass; B: Arterial phase CT showed a non-enhancing mass, consistent with sustained complete response.